SEC Form 4 · accession 0001104659-19-010089
Inspire Medical Systems, Inc. · INSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Buchholz
Officer — Chief Financial Officer
Period of report
Feb 20, 2019
Accepted (ET)
Feb 22, 2019 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609550
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2019 | M | 2,000 | $2.07 | A | 6,750 | D | |
| Common Stock | Feb 20, 2019 | S | 2,000 | $56.87 | D | 4,750 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.07 | Feb 20, 2019 | M | 2,000 | D | — | May 31, 2024 | Common Stock | 2,000 | 74,706 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2The option is fully vested and exercisable.